Kestra Private Wealth Services LLC Has $1.63 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Kestra Private Wealth Services LLC decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,085 shares of the exchange traded fund’s stock after selling 600 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in SPDR S&P Biotech ETF were worth $1,629,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in XBI. Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $29,000. Avior Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares during the period. Tidemark LLC increased its holdings in SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF in the third quarter valued at approximately $40,000. Finally, ORG Wealth Partners LLC bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $44,000.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $89.97 on Thursday. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The stock has a market capitalization of $6.86 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a 50 day moving average price of $92.05 and a two-hundred day moving average price of $96.25.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.